Unmasking New Solutions for OSA

By : Krishna Anindyo | Wednesday, May 20 2020 - 16:43 IWST

Danny Eckert sleep lab
Danny Eckert sleep lab

INDUSTRY co.idOSA, or repetitive upper airway closure during sleep that restricts breathing and is usually accompanied by snoring, has major adverse health, safety and economic impact. Even with established interventions such as continuous positive airway pressure (CPAP), these problems might not resolve.

 

Nearly 1 billion people globally, including 1 million Australians, have obstructive sleep apnoea (OSA) and more targeted treatments are ‘urgently needed’ to reduce the costs and health impacts, say Flinders University experts.

To find better, more effective, individually targeted treatments for people with OSA, Australian Federal Government funding of more than $2 million has been awarded to Flinders University’s Adelaide Institute for Sleep Health.

National Health and Medical Research Council Investigator Leadership grant awardee and Adelaide Institute for Sleep Health Director, Professor Danny Eckert, says a range of issues means OSA is often untreated, and more than 50% of people cannot tolerate long-term use of the main treatment, CPAP.

 

In all, sleep disorders and inadequate sleep cost Australia more than $65 billion per year, and sleep apnoea is the most common, says Matthew Flinders Fellow Professor Eckert.

&ldquo New treatments are urgently needed, and we’re aiming to use and develop novel approaches to identify the causes of OSA on a per patient basis, improve current therapies and management approaches and test if new targeted therapies can be used to treat OSA,” he says. Wednesday (5/20/2020).

“Current diagnosis, treatment and management of OSA are imprecise, are cumbersome, time-consuming, costly and are failing too often because they don’t take into account the differences in the ways people get OSA and the different ways it can present.”

Professor Eckert says his long-running research work takes a four-pronged approach to achieve much-needed improvement in this area of medicine, to Understand the different underlying causes of OSA to identify targets for therapy for each patient, Develop simplified yet more informative clinical tools to fast-track the diagnosis process and inform suitable, targeted treatment solutions for individual patients, Improve existing non-CPAP treatments such as dental devices and develop new drug interventions, Test the efficiency of new therapies, including combination therapies, to treat OSA.

OSA is the most common breathing related sleep disorder, restricting breathing to cause low oxygen levels (hypoxemia) and sleep disruption.

Untreated OSA increases the risk for heart disease and metabolic disorders such as diabetes, impaired cognitive function, cancer, depression, sleepiness, motor vehicle accidents and injury, and all-cause mortality.

News Comment

Today's Industry

PT Autopedia Sukses Lestari Tbk (“ASLC”)

Selasa, 18 Januari 2022 - 23:55 WIB

ASLC Remains Optimistic, Continues IPO Plan

PT Autopedia Sukses Lestari Tbk (“ASLC”) a company engaged in the automotive sector, ranging from car and motorcycle auctions, online car buying and selling, and car and motorcycle price…

Genetech Biotechnology, the exclusive distributor of Citrea

Selasa, 18 Januari 2022 - 23:20 WIB

Genetech Biotechnology Launches Four Exclusive Promo Bundles For Citrea In Celebration Of Chinese New Year

Genetech Biotechnology, the exclusive distributor of Citrea, launches four exclusive promo bundles to celebrate Chinese New Year. The four bundle sets, The Prosperity Bundle, The Pampering Duo,…

The International Labour Organization (ILO)

Selasa, 18 Januari 2022 - 22:50 WIB

ILO downgrades labour market recovery forecast for 2022

he International Labour Organization (ILO) has downgraded its forecast for labour market recovery in 2022, projecting a deficit in hours worked globally equivalent to 52 million full-time jobs,…

Check Point Software Technologies (Images by Acclaim)

Selasa, 18 Januari 2022 - 22:10 WIB

New Requirements in the Wake of Omicron have led to Increased Dark Market Activity Around Fake Covid Certificates

Check Point Research has warned of a resurgence in counterfeit test and vaccination certificates amid a new wave of infections driven by the Omicron variant of COVID-19. Forged certificate vendors…

DBS Bank Ltd.

Selasa, 18 Januari 2022 - 21:37 WIB

DBS Bank tops Debtwire Asia Pacific (ex Japan) Loans League Table for Green and Sustainability-Linked Mandated Lead Arranger

DBS Bank has ranked first in Debtwire’s Asia Pacific (ex Japan) loans league table for its role as Green and Sustainability-Linked Mandated Lead Arranger (MLA) for the full year 2021. This…